Product NDC: | 60505-2530 |
Proprietary Name: | ziprasidone hydrochloride |
Non Proprietary Name: | Ziprasidone HCl |
Active Ingredient(s): | 60 mg/1 & nbsp; Ziprasidone HCl |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-2530 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077561 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120514 |
Package NDC: | 60505-2530-0 |
Package Description: | 8 BLISTER PACK in 1 CARTON (60505-2530-0) > 10 CAPSULE in 1 BLISTER PACK |
NDC Code | 60505-2530-0 |
Proprietary Name | ziprasidone hydrochloride |
Package Description | 8 BLISTER PACK in 1 CARTON (60505-2530-0) > 10 CAPSULE in 1 BLISTER PACK |
Product NDC | 60505-2530 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ziprasidone HCl |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120514 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | ZIPRASIDONE HYDROCHLORIDE |
Strength Number | 60 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC],Atypical Antipsychotic [EPC] |